Download PDF
Sportphysio 2018; 06(04): 153-159
DOI: 10.1055/a-0642-8160
Focus
Einführung
© Georg Thieme Verlag KG Stuttgart · New York

Exercise is medicine: Die Rolle von Zytokinen und Myokinen für Gesundheit und Krankheit

Patrick Wahl
Further Information

Publication History

Publication Date:
07 September 2018 (online)

    Permissions and Reprints

Zusammenfassung

Die Skelettmuskulatur ist das größte Organ normalgewichtiger Personen. Mittlerweile wird sie als aktives sekretorisches Organ betrachtet. Ausgelöst durch Kontraktion sezerniert die Muskulatur regulatorische Myokine, die u. a. den sogenannten „Organ Cross-Talk“ vermitteln, die Kommunikation zwischen der Skelettmuskulatur und anderen Teilen des Organismus. Den Myokinen werden viele gesundheitsfördernde Effekte zugeschrieben. Sie wirken positiv auf den Metabolismus und unterdrücken Entzündungen.

 

  • Literatur

  • 1 Nocon M, Hiemann T, Muller-Riemenschneider F. et al. Association of physical activity with all-cause and cardiovascular mortality: A systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil 2008; 15 (03) 239-246 doi:10.1097/HJR.0b013e3282f55e09
    CrossrefPubMedGoogle Scholar
  • 2 Bronnum-Hansen H, Juel K, Davidsen M. et al. Impact of selected risk factors on expected lifetime without long-standing, limiting illness in Denmark. Prev Med 2007; 45 (01) 49-53 doi:10.1016/j.ypmed.2007.03.010
    CrossrefGoogle Scholar
  • 3 Monninkhof EM, Elias SG, Vlems FA. et al. Physical activity and breast cancer: A systematic review. Epidemiology 2007; 18: 137-57 doi:10.1097/01.ede.0000251167.75581.98
    CrossrefGoogle Scholar
  • 4 Paffenbarger Jr RS, Lee IM, Leung R. Physical activity and personal characteristics associated with depression and suicide in American college men. Acta Psychiatr Scand Suppl 1994; 377: 16-22 doi:10.1111/j.1600–0447.1994.tb05796.x
    Google Scholar
  • 5 Rovio S, Kareholt I, Helkala EL. et al. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer’s disease. Lancet Neurol 2005; 4: 705-711 doi:10.1016/S1474–4422(05)70198–8
    CrossrefGoogle Scholar
  • 6 Tuomilehto J, Lindstrom J, Eriksson JG. et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance”. N Engl J Med 2001; 344 (18) 1343-50 doi:10.1056/NEJM200105033441801
    CrossrefPubMedGoogle Scholar
  • 7 Wolin KY, Yan Y, Colditz GA. et al. Physical activity and colon cancer prevention: A meta-analysis. Br. J. Cancer 2009; 100: 611-6 doi:10.1038/sj.bjc.6604917
    CrossrefGoogle Scholar
  • 8 Knowler WC, Barrett-Connor E, Fowler SE. et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346 (06) 393-403 doi: 10.1056/NEJMoa012512
    CrossrefPubMedGoogle Scholar
  • 9 Eckardt K, Görgens SW, Raschke S. et al. Myokines in insulin resistance and type 2 diabetes. Diabetologia 2014; 57 (06) 1087-99 doi:10.1007/s00125–014–3224-x
    CrossrefPubMedGoogle Scholar
  • 10 Pedersen BK. Muscles and their myokines. J Exp Biol 2011; 214 (Pt 2) 337-46 doi:10.1242/jeb.048074
    CrossrefGoogle Scholar
  • 11 Fischer CP, Berntsen A, Perstrup LB. et al. Plasma levels of interleukin-6 and C-reactive protein are associated with physical inactivity independent of obesity. Scand J Med Sci Sports 2007; 17: 580-587 doi:10.1111/j.1600–0838.2006.00602.x
    Google Scholar
  • 12 Bruunsgaard H, Pedersen AN, Schroll M. et al. Impaired production of proinflammatory cytokines in response to lipopolysaccharide (LPS) stimulation in elderly humans. Clin Exp Immunol 1999; 118 (02) 235-241 doi:10.1046/j.1365–2249.1999.01045.x
    CrossrefGoogle Scholar
  • 13 Bruunsgaard H, Pedersen BK. Age-related inflammatory cytokines and disease. Immunology and Allergy Clinics of North America 2003; 23 (01) 15-39 doi:10.1016/S0889–8561(02)00056–5
    CrossrefGoogle Scholar
  • 14 Mathur N, Pedersen BK. Exercise as a mean to control low-grade systemic inflammation. Mediators of Inflammation. Vol. 2008, Article ID 109502, 6 pages. DOI: doi:10.1155/2008/109502
    Google Scholar
  • 15 Wahl P, Mathes S, Köhler K. et al. Acute metabolic, hormonal, and psychological responses to different endurance training protocols. Horm Metab Res 2013; 45 (11) 827-33 doi:10.1055/s-0033–1347242
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Handschin C, Spiegelman BM. The role of exercise and PGC1α in inflammation and chronic disease. Nature 2008; 454 (7203) 463-469 doi:10.1038/nature07206
    Google Scholar
  • 17 Nieman DC. Current perspective on exercise immunology. Curr Sports Med Rep 2003; 2 (05) 239-42
    CrossrefGoogle Scholar
  • 18 Ostrowski K, Rohde T, Asp S. et al. Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol 1999; 515 part 1 287-291 doi:10.1111/j.1469–7793.1999.287ad.x
    CrossrefGoogle Scholar
  • 19 Brandt C, Pedersen BK. The role of exercise-induced myokines in muscle homeostasis and the defense against chronic diseases. J Biomed Biotechnol 2010; 2010: 520258 doi:10.1155/2010/520258
    Google Scholar
  • 20 Hawley JA, Hargreaves M, Joyner MJ. et al. Integrative biology of exercise. Cell 2014; 159 (04) 738-49 doi:10.1016/j.cell.2014.10.029
    CrossrefGoogle Scholar
  • 21 Catoire M, Kersten S. The search for exercise factors in humans. FASEB J 2015; 29 (05) 1615-28 doi:10.1096/fj.14–263699
    CrossrefGoogle Scholar
  • 22 Pedersen BK, Edward F. Adolph distinguished lecture: Muscle as an endocrine organ: IL-6 and other myokines. J Appl Physiol 2009; 107 (04) 1006-14 doi:10.1152/japplphysiol.00734.2009
    CrossrefGoogle Scholar
  • 23 Pedersen BK, Pedersen M, Krabbe KS. et al. Role of exercise induced brain-derived neurotrophic factor production in the regulation of energy homeostasis in mammals. Exp Physiol 2009; 94 (12) 1153-60 doi:10.1113/expphysiol.2009.048561
    CrossrefGoogle Scholar
  • 24 Broholm C, Mortensen OH, Nielsen S. et al. Exercise induces expression of leukaemia inhibitory factor in human skeletal muscle. Journal of Physiology 2008; 586 (08) 2195-2201 doi:10.1113/jphysiol.2007.149781
    CrossrefGoogle Scholar
  • 25 Izumiya Y, Bina HA, Ouchi N. et al. FGF21 is an Akt-regulated myokine. FEBS Letters 2008; 582 (27) 3805-10 doi:10.1016/j.febslet.2008.10.021
    CrossrefGoogle Scholar
  • 26 Ouchi N, Oshima Y, Ohashi K. et al. Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric oxide synthase-dependent mechanism. J Biol Chem 2008; 283 (47) 32802-11 doi:10.1074/jbc.M803440200
    CrossrefGoogle Scholar
  • 27 Yoon JH, Kim J, Song P. Secretomics for skeletal muscle cells: A discovery of novel regulators?. Adv Biol Regul 2012; 52 (02) 340-350 doi:10.1016/j.jbior.2012.03.001
    CrossrefGoogle Scholar
  • 28 Nieto-Vazquez I, Fernandez-Veledo S, de Alvaro C. et al. Dual role of interleukin-6 in regulating insulin sensitivity in murine skeletal muscle. Diabetes 2008; 57: 3211-21 doi:10.2337/db07–1062
    CrossrefGoogle Scholar
  • 29 Pedersen BK, Febbraio MA. Muscle as an endocrine organ: Focus on muscle-derived interleukin-6. Physiol Rev 2008; 88 (04) 1379-1406 doi:10.1152/physrev.90100.2007
    CrossrefPubMedGoogle Scholar
  • 30 Steensberg A, van Hall G, Osada T. et al. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol 2000; 529: 237-242 doi:10.1111/j.1469–7793.2000.00237.x
    CrossrefGoogle Scholar
  • 31 Steensberg A, Febbraio MA, Osada T. et al. Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content. J Physiol 2001; 537: 633-39 doi:10.1111/j.1469–7793.2001.00633.x
    CrossrefGoogle Scholar
  • 32 Keller C, Steensberg A, Pilegaard H. et al. Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: Influence of muscle glycogen content. FASEB J 2001; 15: 2748-2750 doi:10.1096/fj.01–0507fje
    CrossrefGoogle Scholar
  • 33 Starkie R, Ostrowski SR, Jauffred S. et al. Exercise and IL-6 infusion inhibit endotoxininduced TNF-alpha production in humans. FASEB J 2003; 17 (08) 884-6 doi:10.1096/fj.02–0670fje
    CrossrefGoogle Scholar
  • 34 Steensberg A, Fischer CP, Keller C. et al. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab 2003; 285 (02) E433-7 doi:10.1152/ajpendo.00074.2003
    CrossrefPubMedGoogle Scholar
  • 35 Nielsen AR, Pedersen BK. The biological roles of exercise-induced cytokines: IL-6, IL-8, and IL-15. Applied Physiology, Nutrition and Metabolism 2007; 32 (05) 833-39 doi:10.1139/H07–054
    CrossrefGoogle Scholar
  • 36 Thornton SM, Krolopp JE, Abbott MJ. IL-15 Mediates mitochondrial activity through a PPARδ-dependent-PPARα-independent mechanism in skeletal muscle cells. PPAR Res. 2016; 2016: 5465804 doi:10.1155/2016/5465804
    Google Scholar
  • 37 Busquets S, Figueras MT, Meijsing S. et al. Interleukin-15 decreases proteolysis in skeletal muscle: A direct effect. Int J Mol Med 2005; 16: 471-476 doi:10.3892/ijmm.16.3.471
    Google Scholar
  • 38 Krolopp JE, Thornton SM, Abbott MJ. IL-15 activates the Jak3/STAT3 signaling pathway to mediate glucose uptake in skeletal muscle cells. Front Physiol 2016; 7: 626 doi:10.3389/fphys.2016.00626
    Google Scholar
  • 39 Nieman DC, Davis JM, Brown VA. et al. Influence of carbohydrate ingestion on immune changes after 2 h of intensive resistance training. J Appl Physiol 2004; 96: 1292-8 doi:10.1152/japplphysiol.01064.2003
    CrossrefGoogle Scholar
  • 40 Nielsen AR, Mounier R, Plomgaard P. et al. Expression of interleukin-15 in human skeletal muscle effect of exercise and muscle fibre type composition. J Physiol 2007; 584: 305-12 doi:10.1113/jphysiol.2007.139618
    CrossrefGoogle Scholar
  • 41 Tamura Y, Watanabe K, Kantani T. et al. Upregulation of circulating IL-15 by treadmill running in healthy individuals: Is IL-15 an endocrine mediator of the beneficial effects of endurance exercise?. Endocr J 2011; 58: 211-15 doi:10.1507/endocrj.K10E-400
    CrossrefGoogle Scholar
  • 42 Yeo NH, Woo J, Shin KO. et al. The effects of different exercise intensity on myokine and angiogenesis factors. J Sports Med Phys Fitness 2012; 52 (04) 448-54
    Google Scholar
  • 43 Riechman SE, Balasekaran G, Roth SM. et al. Association of interleukin-15 protein and interleukin-15 receptor genetic variation with resistance exercise training responses. J Appl Physiol 2004; 97: 2214-19 doi:10.1152/japplphysiol.00491.2004
    CrossrefPubMedGoogle Scholar
  • 44 Matthews VB, Astrom MB, Chan MH. et al. Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase. Diabetologia 2009; 52 (07) 1409-18 doi:10.1007/s00125–009–1364–1
    CrossrefPubMedGoogle Scholar
  • 45 Krabbe KS, Nielsen AR, Krogh-Madsen R. et al. Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia 2007; 50 (02) 431-8 doi:10.1007/s00125–006–0537–4
    CrossrefPubMedGoogle Scholar
  • 46 Wahl P, Hein M, Achtzehn S. et al. Acute effects of superimposed electromyostimulation during cycling on myokines and markers of muscle damage. J Musculoskelet Neuronal Interact 2015; 15 (01) 53-9
    PubMedGoogle Scholar
  • 47 Rasmussen P, Brassard P, Adser H. et al. Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exp Physiol 2009; 94: 1062-69 doi:10.1113/expphysiol.2009.048512
    CrossrefPubMedGoogle Scholar
  • 48 Huh JY. The role of exercise-induced myokines in regulating metabolism. Arch Pharm Res 2018; 41 (01) 14-29 doi:10.1007/s12272–017–0994-y
    CrossrefGoogle Scholar
  • 49 Huh JY, Mougios V, Kabasakalis A. et al. Exercise-induced irisin secretion is independent of age or fitness level and increased irisin may directly modulate muscle metabolism through AMPK activation. J Clin Endocrinol Metab 2014; 99: E2154-E2161 doi:10.1210/jc.2014–1437
    CrossrefGoogle Scholar
  • 50 Perakakis N, Triantafyllou GA, Fernandez-Real JM. et al. Physiology and role of irisin in glucose homeostasis. Nat Rev Endocrinol 2017; 13: 324-337 doi:10.1038/nrendo.2016.221
    Google Scholar
  • 51 Daskalopoulou SS, Cooke AB, Gomez YH. et al. Plasma irisin levels progressively increase in response to increasing exercise workloads in young, healthy, active subjects. Eur J Endocrinol 2014; 171 (03) 343-352 doi:10.1530/EJE-14–0204
    CrossrefPubMedGoogle Scholar
  • 52 Jedrychowski MP, Wrann CD, Paulo JA. et al. Detection and quantitation of circulating human irisin by tandem mass spectrometry. Cell Metab 2015; 22 (04) 734-740 doi:10.1016/j.cmet.2015.08.001
    CrossrefPubMedGoogle Scholar
  • 53 McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997; 387: 83-90
    CrossrefGoogle Scholar